Dimensional Fund Advisors
BEAM icon

Dimensional Fund Advisors’s Beam Therapeutics BEAM Stock Holding History

Dimensional Fund Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.3M Buy
2,154,575
+206,696
+11% +$5.74M 0.01% 1489
2025
Q4 		$54M Buy
1,947,879
+227,589
+13% +$5.81M 0.01% 1463
2025
Q3 		$41.7M Sell
1,720,290
-38,379
-2% -$763K 0.01% 1616
2025
Q2 		$29.9M Buy
1,758,669
+162,617
+10% +$2.83M 0.01% 1786
2025
Q1 		$31.2M Buy
1,596,052
+57,654
+4% +$1.51M 0.01% 1727
2024
Q4 		$38.2M Buy
1,538,398
+298,067
+24% +$7.61M 0.01% 1676
2024
Q3 		$30.4M Buy
1,240,331
+190,971
+18% +$4.93M 0.01% 1792
2024
Q2 		$24.6M Buy
1,049,360
+407,499
+63% +$10M 0.01% 1865
2024
Q1 		$21.2M Buy
641,861
+75,003
+13% +$2.34M 0.01% 1954
2023
Q4 		$15.4M Buy
566,858
+149,851
+36% +$3.72M ﹤0.01% 2114
2023
Q3 		$10M Buy
417,007
+132,381
+47% +$3.55M ﹤0.01% 2255
2023
Q2 		$9.09M Buy
284,626
+104,255
+58% +$3.38M ﹤0.01% 2299
2023
Q1 		$5.52M Buy
180,371
+55,946
+45% +$2.21M ﹤0.01% 2454
2022
Q4 		$4.87K Buy
124,425
+110,050
+766% +$4.93M ﹤0.01% 2468
2022
Q3 		$685K Sell
14,375
-3,754
-21% -$214K ﹤0.01% 2978
2022
Q2 		$702K Sell
18,129
-443
-2% -$17.6K ﹤0.01% 2991
2022
Q1 		$1.06M Buy
18,572
+7,910
+74% +$519K ﹤0.01% 2978
2021
Q4 		$850K Buy
10,662
+295
+3% +$25.3K ﹤0.01% 3063
2021
Q3 		$902K Buy
10,367
+4,886
+89% +$491K ﹤0.01% 3066
2021
Q2 		$705K Sell
5,481
-18
-0.3% -$1.43K ﹤0.01% 3092
2021
Q1 		$440K Buy
+5,499
New +$523K ﹤0.01% 3167

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Dimensional Fund Advisors's BEAM Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Beam Therapeutics (BEAM) stake by 11% in Q1 2026, buying an estimated $5.74M and bringing the position to 2,154,575 shares worth $51.3M. The position accounts for 0.01% of the portfolio, ranked #1489.

Dimensional Fund Advisors first reported a position in BEAM in Q1 2021 and has held it in 21 quarters since. The position peaked at $54M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Dimensional Fund Advisors held 2,154,575 shares of Beam Therapeutics worth $51.3M as of Q1 2026.
  • Dimensional Fund Advisors bought 206,696 Beam Therapeutics shares in Q1 2026, an estimated $5.74M.
  • Beam Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #1489 holding.
  • Dimensional Fund Advisors first reported a position in Beam Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Dimensional Fund Advisors's Beam Therapeutics position peaked at $54M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.